Skip to main content
. 2021 Jun 11;8:657087. doi: 10.3389/fmolb.2021.657087

FIGURE 9.

FIGURE 9

Nomogram prediction of overall survival (OS) of LUAD and LUSC patients. (A) Construction of AS clinicopathological nomograms using AS risk signature and pathological stage. The nomogram was then used to predict the 1-, 3-, and 5-year OS of LUAD patients. (B) The nomogram AS clinicopathological nomogram calibration plot in LUAD. It predicts 1-, 3-, and 5-year prognoses. (C) Construction of AS clinicopathological nomograms using AS risk signature and T stage. The nomogram was then used to predict 1-, 3-, and 5- OS of LUSC patients. (D) The AS clinicopathological nomogram calibration plot. It predicts the 1-, 3-, and 5-year prognosis of LUSC. AS, alternative splicing; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; OS, overall survival.